Page 2 - Graybug Vision News Today

International expansion of CARPO, a Phase 2b clinical trial of Auxora in acute pancreatitis patients with accompanying systemic inflammatory response syndrome , in India Expansion of team with key... -Today at 04:08 pm- MarketScreener

/PRNewswire/ -- Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases,...

MarkNtel Advisors is dedicated to delivering in-depth & comprehensive market research study. Their reports are known for providing unbiased inform

The Retinal Vein Occlusion Treatment Market refers to the pharmaceuticals and medical devices used to manage and treat retinal vein occlusion, a condition where a vein in the retina becomes blocked or partially blocked. RVO can lead to vision loss or impairment if left untreated.There are two main types of retinal v...

/PRNewswire/ -- DelveInsights Geographic Atrophy Market Insights report includes a comprehensive understanding of current treatment practices, geographic...

LA JOLLA, Calif., May 15, 2023 -- CalciMedica Inc. , a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need,... | May 15, 2023

The Diabetic Retinopathy market report provides current treatment practices, Diabetic Retinopathy emerging drugs, Diabetic Retinopathy market share of the

The days when a pre-revenue biotech company can raise a lot of money through a public listing are gone for now.

/PRNewswire/ -- Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, announced today the...

- CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC”- Cash and cash equivalents of...